Treatment of hepatitis C virus (HCV) infection has experienced a major advancement with
the advent of the new direct acting antivirals (DAA). Current HCV infection cure rates exceed …

Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular
carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment …

We read with great interest the report by Reig et al. published in a recent issue of the Journal
of Hepatology [1]. Reig et al. observed an unexpected high rate of early recurrence of …

Στην παρούσα προοπτική μελέτη από 4 νοσοκομεία της Ισπανίας περιλήφθηκαν ασθενείς, οι
οποίοι ανταποκρίθηκαν πλήρως στη θεραπεία του ηπατοκυτταρικού καρκίνου με χειρουργική …

Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular
carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment …

Treatment of hepatitis C virus (HCV) infection has experienced a major advancement with
the advent of the new direct acting antivirals (DAA). Current HCV infection cure rates exceed …

Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular
carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment …

Treatment of hepatitis C virus (HCV) infection has experienced a major advancement with
the advent of the new direct acting antivirals (DAA). Current HCV infection cure rates exceed …

Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular
carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and …

Treatment of hepatitis C virus (HCV) infection has experienced a major advancement with
the advent of the new direct acting antivirals (DAA). Current HCV infection cure rates exceed …